 Cancer Research UK | Genetically modified immunotherapy shows promise in B-cell acute leukaemia Cancer Research UK Dr Renier Brentjens and his team at the Memorial Sloan-Kettering Cancer Center in New York set out to develop a treatment aimed at B-ALL patients who had chemotherapy, but who had relapsed and were ineligible for a stem cell transplant. The researchers ... |
